Lanxess shares dropped sharply after it downgraded its year-end earnings expectations, with some analysts questioning the success of the chemical company’s M&A strategy.
Lanxess shares dropped sharply after it downgraded its year-end earnings expectations, with some analysts questioning the success of the chemical company’s M&A strategy.